Sumitomo Chemical India Limited (NSE:SUMICHEM)
India · Delayed Price · Currency is INR | Market Cap | 216.98B -23.9% |
| Revenue (ttm) | 32.34B +2.9% |
| Net Income | 5.31B +3.0% |
| EPS | 10.65 +3.2% |
| Shares Out | 499.15M |
| PE Ratio | 40.83 |
| Forward PE | 35.18 |
| Dividend | 1.20 (0.28%) |
| Ex-Dividend Date | Jul 25, 2025 |
| Volume | 136,979 |
| Average Volume | 236,086 |
| Open | 452.50 |
| Previous Close | 447.60 |
| Day's Range | 432.70 - 452.50 |
| 52-Week Range | 362.60 - 665.00 |
| Beta | -0.03 |
| RSI | 60.03 |
| Earnings Date | May 26, 2026 |
About Sumitomo Chemical India
Sumitomo Chemical India Limited engages in the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition products in India and internationally. It also offers crop protection products, such as insecticides, herbicides, fungicides, and miticides; animal nutrition; plant nutrition and plant growth regulators; fumigants and rodenticides; weedicides; and biological products. The company was incorporated in 2000 and is headquartered in Mumbai, India. Sumitomo Chemical India Limited is a subsidiar... [Read more]
Financial Performance
In fiscal year 2025, Sumitomo Chemical India's revenue was 31.49 billion, an increase of 10.71% compared to the previous year's 28.44 billion. Earnings were 5.05 billion, an increase of 36.79%.
Financial StatementsNews
Sumitomo Chemical India Ltd (BOM:542920) Q2 2026 Earnings Call Highlights: Navigating ...
Sumitomo Chemical India Ltd (BOM:542920) Q2 2026 Earnings Call Highlights: Navigating Challenges with Strategic Growth and Innovation
Q2 2026 Sumitomo Chemical India Ltd Earnings Call Transcript
Q2 2026 Sumitomo Chemical India Ltd Earnings Call Transcript
Sumitomo Chemical India Transcript: Q2 25/26
H1 FY26 saw 9% revenue and 11% profit growth year-on-year, despite Q2 weather disruptions. Margins and cash position remain strong, with new product launches exceeding expectations and major CapEx planned for future growth.
Sumitomo Chemical India Q1 Results: Net profit rises 41% YoY to Rs 178 crore, Revenue grows 26%
Sumitomo Chemical India reported a 40.8% year-on-year (YoY) rise in consolidated net profit at Rs 178.3 crore for the quarter ended June 30, 2025, compared to Rs 126.6 crore in the same quarter last y...
Sumitomo Chemical India Transcript: Q4 24/25
Achieved double-digit revenue and profit growth in FY25, driven by strong domestic and export volume gains, margin expansion, and new product launches. Strategic CapEx and operational efficiency position the company for continued growth in FY26 amid a favorable market outlook.
Sumitomo Chemical shares drop nearly 4% as Q4 EBITDA falls 14.7% YoY to Rs 120 crore
Sumitomo Chemical India witnessed a nearly 4% drop in its share price during morning trade after the company released its financial results for the fourth quarter of FY25. As of 9:32 AM, the shares we...
Q4 earning results today: Aurobindo, Gillette, KEC, FirstCry among key earnings to watch on 26 May
More than 50 listed companies are set to declare their Q4FY25 earnings on 26 May 2025, keeping the focus squarely on stock-specific action. Key companies scheduled to report include Aurobindo Pharma, ...
Chemicals Stocks Update: DDEV up 4.81%, Gujarat Fluorochemicals down 4.79%, Camlin Fine Chemicals down 3.15% and more
The S&P BSE Chemicals Index showed mixed movements today. Here’s a detailed update on the performance of key players in the sector: Top Gainers DDEV Plastiks: BSE ₹288.60 (4.81%↑), NSE Not Listed. Sum...
Sumitomo Chemical India Transcript: Q2 24/25
Q2 and H1 FY25 saw double-digit revenue and profit growth, with gross and EBITDA margins at record highs due to strong volume growth, new product launches, and export recovery. Management expects robust H2 demand, stable margins, and continued product innovation, with major CapEx planned at Dahej.